BioHealth News Archive
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor
ROCKVILLE, Md., Sept. 21, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies…
Read MoreWhite House Unveils Strategy To Grow Trillion Dollar U.S. Bioeconomy
The U.S. bioeconomy is booming. Valued at nearly one trillion dollars and predicted to grow globally to over $30 trillion over the next two…
Read MoreUCSF scientist says Biden’s cancer moonshot achievable
OAKLAND, Calif. - President Biden revived his call for a nationwide cancer moonshot effort on Monday, as he marked the 60th anniversary of President…
Read MoreThe Venture Capital Landscape Is Changing, and Perhaps Not for the Better | Maryland Smith
Startup companies have traditionally looked for the most experienced venture capitalists they could find to get their businesses off the ground and support their…
Read MoreThe University of Maryland Medical System is investing $14M in statewide economic development – Technical.ly
One of Maryland’s premiere medical networks just announced an eight-figure investment into the economic development of local and marginalized communities by way of notable…
Read MoreVirginia’s AMPEL BioSolutions New Breakthrough Test Detects and Predicts Severity of COVID-19
CHARLOTTESVILLE, Va., Sept. 15, 2022 /PRNewswire/ -- AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in…
Read MoreQ32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases
Waltham, Mass. and Dublin – August 15, 2022 — Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced…
Read MoreStreck Announces Series B Investment in Virginia’s Ceres Nanosciences
La Vista, Nebraska — September 14, 2022 – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment…
Read MoreSwimming With Sharks
Swimming with Sharks pairs aspiring healthcare entrepreneurs with successful innovators and investors. The startups selected will pitch at the American Society of Anesthesiologists (ASA)…
Read MoreMaryland Stem Cell Research Commission Announces Over $4 Million in Awards to Accelerate Cures | MSCRF
September 13, 2022—The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that will strengthen and advance…
Read MoreHorizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint
- The Company plans to work with the FDA to design a Phase 3 program in moderate-to-high systemic disease activity patients to begin in 2023, ahead…
Read MoreBiden Spurs U.S. Biotechnology with New Order – Nextgov
The Biden administration announced the launch of a new national program dedicated to fortifying America’s biotechnology manufacturing industry in the latest executive effort to…
Read MoreQiagen joins monkeypox test-making efforts
As the number of monkeypox cases around the world has ballooned since early May, so too has the list of diagnostic developers rapidly churning…
Read MoreAlexandria Real Estate Equities, Inc. Recognizes Important Milestones in Its Pioneering of New York City’s Commercial Life Science Cluster, the Only Early-Stage Life Science Ecosystem Among the Major Life Science Clusters in the United States
NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ( NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer uniquely…
Read MoreFinalists Selected For 7th Annual BioHealth Capital Region Crab Trap Competition
– Winner to be announced as part 2022 BioHealth Capital Region Forum – ROCKVILLE, MARYLAND, September 12, 2022 – A panel of investor judges…
Read More